These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 8208317
1. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia. Koníková E, Babusíková O, Mesárosová A, Kusenda J, Glasová M. Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317 [Abstract] [Full Text] [Related]
2. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J, Babusíková O. Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [Abstract] [Full Text] [Related]
3. Surface and cytoplasmic immunoglobulin expression in B-cell chronic lymphocytic leukemia (CLL). Lewis RE, Cruse JM, Pierce S, Lam J, Tadros Y. Exp Mol Pathol; 2005 Oct; 79(2):146-50. PubMed ID: 15963979 [Abstract] [Full Text] [Related]
4. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y. Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [Abstract] [Full Text] [Related]
5. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M. Neoplasma; 1993 Apr; 40(5):275-81. PubMed ID: 8272155 [Abstract] [Full Text] [Related]
7. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells. Babusíková O, Mesárosová A, Kusenda J, Koníková E, Klobusická M, Hrivnáková A. Neoplasma; 1995 Apr; 42(5):221-6. PubMed ID: 8552199 [Abstract] [Full Text] [Related]
8. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation. Nelson BP, Variakojis D, Peterson LC. Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788 [Abstract] [Full Text] [Related]
15. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. Zucchetto A, Bomben R, Dal Bo M, Sonego P, Nanni P, Rupolo M, Bulian P, Dal Maso L, Del Poeta G, Del Principe MI, Degan M, Gattei V. J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666 [Abstract] [Full Text] [Related]
19. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. Royston I, Majda JA, Baird SM, Meserve BL, Griffiths JC. J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560 [Abstract] [Full Text] [Related]
20. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia. Koníková E, Kusenda J, Babusíková O, Glasová M. Neoplasma; 1995 Aug; 42(5):227-34. PubMed ID: 8552200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]